These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 24854377)

  • 1. Tocilizumab in refractory aortitis: study on 16 patients and literature review.
    Loricera J; Blanco R; Castañeda S; Humbría A; Ortego-Centeno N; Narváez J; Mata C; Melchor S; Aurrecoechea E; Calvo-Alén J; Lluch P; Moll C; Mínguez M; Herrero-Beaumont G; Bravo B; Rubio E; Freire M; Peiró E; González-Vela C; Rueda-Gotor J; Pina T; Palmou-Fontana N; Calvo-Río V; Ortiz-Sanjuán F; González-Gay MÁ
    Clin Exp Rheumatol; 2014; 32(3 Suppl 82):S79-89. PubMed ID: 24854377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.
    Unizony S; Arias-Urdaneta L; Miloslavsky E; Arvikar S; Khosroshahi A; Keroack B; Stone JR; Stone JH
    Arthritis Care Res (Hoboken); 2012 Nov; 64(11):1720-9. PubMed ID: 22674883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tocilizumab as an add-on therapy to glucocorticoids during the first 3 months of treatment of Giant cell arteritis: A prospective study.
    Samson M; Devilliers H; Ly KH; Maurier F; Bienvenu B; Terrier B; Charles P; Guillevin L; Besancenot JF; Liozon E; Fauchais AL; Loffroy R; Binquet C; Audia S; Seror R; Mariette X; Bonnotte B
    Eur J Intern Med; 2018 Nov; 57():96-104. PubMed ID: 30054122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tocilizumab in giant cell arteritis: Multicenter open-label study of 22 patients.
    Loricera J; Blanco R; Hernández JL; Castañeda S; Mera A; Pérez-Pampín E; Peiró E; Humbría A; Calvo-Alén J; Aurrecoechea E; Narváez J; Sánchez-Andrade A; Vela P; Díez E; Mata C; Lluch P; Moll C; Hernández Í; Calvo-Río V; Ortiz-Sanjuán F; González-Vela C; Pina T; González-Gay MÁ
    Semin Arthritis Rheum; 2015 Jun; 44(6):717-23. PubMed ID: 25697557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial analysis of clinical and imaging indices reveals prolonged efficacy of TNF-α and IL-6 receptor targeted therapies in refractory Takayasu arteritis.
    Youngstein T; Peters JE; Hamdulay SS; Mewar D; Price-Forbes A; Lloyd M; Jeffery R; Kinderlerer AR; Mason JC
    Clin Exp Rheumatol; 2014; 32(3 Suppl 82):S11-8. PubMed ID: 24093733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of tocilizumab in conventional treatment-refractory adult-onset Still's disease: multicenter retrospective open-label study of thirty-four patients.
    Ortiz-Sanjuán F; Blanco R; Calvo-Rio V; Narvaez J; Rubio Romero E; Olivé A; Castañeda S; Gallego Flores A; Hernández MV; Mata C; Ros Vilamajo I; Sifuentes Giraldo WA; Caracuel MA; Freire M; Gómez Arango C; Llobet J; Manrique Arija S; Marras C; Moll-Tuduri C; Plasencia-Rodriguez C; Roselló R; Urruticoechea A; Velloso-Feijoo ML; Del Blanco J; González-Vela MC; Rueda-Gotor J; Pina T; Loricera J; González-Gay MA
    Arthritis Rheumatol; 2014 Jun; 66(6):1659-65. PubMed ID: 24515813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tocilizumab, an effective treatment for relapsing giant cell arteritis.
    Oliveira F; Butendieck RR; Ginsburg WW; Parikh K; Abril A
    Clin Exp Rheumatol; 2014; 32(3 Suppl 82):S76-8. PubMed ID: 24854376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-infectious aortitis: a report of 32 cases from a single tertiary centre in a 4-year period and literature review.
    Loricera J; Blanco R; Hernández JL; Carril JM; Martínez-Rodríguez I; Canga A; Peiró E; Alonso-Gutiérrez J; Calvo-Río V; Ortiz-Sanjuán F; Mata C; Pina T; González-Vela MC; Martínez-Amador N; González-Gay MA
    Clin Exp Rheumatol; 2015; 33(2 Suppl 89):S-19-31. PubMed ID: 25437450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of refractory Takayasu arteritis with tocilizumab: 7 Italian patients from a single referral center.
    Tombetti E; Franchini S; Papa M; Sabbadini MG; Baldissera E
    J Rheumatol; 2013 Dec; 40(12):2047-51. PubMed ID: 24187104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of anti-interleukin 6 receptor monoclonal antibody (tocilizumab) in Colombian patients with Takayasu arteritis.
    Cañas CA; Cañas F; Izquierdo JH; Echeverri AF; Mejía M; Bonilla-Abadía F; Tobón GJ
    J Clin Rheumatol; 2014 Apr; 20(3):125-9. PubMed ID: 24662551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tocilizumab in patients with Takayasu arteritis: a retrospective study and literature review.
    Loricera J; Blanco R; Hernández JL; Castañeda S; Humbría A; Ortego N; Bravo B; Freire M; Melchor S; Mínguez M; Salvatierra J; González-Vela C; Calvo-Río V; Santos-Gómez M; Pina T; González-Gay MA
    Clin Exp Rheumatol; 2016; 34(3 Suppl 97):S44-53. PubMed ID: 27050507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of tocilizumab highlighted by FDG-PET/CT in a patient with relapsing polychondritis-associated aortitis.
    Elourimi G; Soussan M; Warzocha U; Bugaud H; Dhôte R; Abad S
    Rheumatol Int; 2017 Nov; 37(11):1931-1935. PubMed ID: 28965131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-interleukin 6 receptor tocilizumab in refractory uveitis associated with Behçet's disease: multicentre retrospective study.
    Atienza-Mateo B; Calvo-Río V; Beltrán E; Martínez-Costa L; Valls-Pascual E; Hernández-Garfella M; Atanes A; Cordero-Coma M; Miquel Nolla J; Carrasco-Cubero C; Loricera J; González-Vela MC; Vegas-Revenga N; Fernández-Díaz C; Demetrio-Pablo R; Domínguez-Casas LC; Luis Martín-Varillas J; Palmou-Fontana N; Hernández JL; González-Gay MÁ; Blanco R
    Rheumatology (Oxford); 2018 May; 57(5):856-864. PubMed ID: 29471416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tocilizumab: a novel therapy for patients with large-vessel vasculitis.
    Salvarani C; Magnani L; Catanoso M; Pipitone N; Versari A; Dardani L; Pulsatelli L; Meliconi R; Boiardi L
    Rheumatology (Oxford); 2012 Jan; 51(1):151-6. PubMed ID: 22075063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Interleukin-6 Receptor Tocilizumab for Severe Juvenile Idiopathic Arthritis-Associated Uveitis Refractory to Anti-Tumor Necrosis Factor Therapy: A Multicenter Study of Twenty-Five Patients.
    Calvo-Río V; Santos-Gómez M; Calvo I; González-Fernández MI; López-Montesinos B; Mesquida M; Adán A; Hernández MV; Maíz O; Atanes A; Bravo B; Modesto C; Díaz-Cordovés G; Palmou-Fontana N; Loricera J; González-Vela MC; Demetrio-Pablo R; Hernández JL; González-Gay MA; Blanco R
    Arthritis Rheumatol; 2017 Mar; 69(3):668-675. PubMed ID: 27696756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tocilizumab for polymyalgia rheumatica: report of two cases and review of the literature.
    Macchioni P; Boiardi L; Catanoso M; Pulsatelli L; Pipitone N; Meliconi R; Salvarani C
    Semin Arthritis Rheum; 2013 Aug; 43(1):113-8. PubMed ID: 23433960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninfectious aortitis: Experience with tocilizumab in a regional hospital.
    Aldasoro Cáceres V; Ibáñez Bosch R; Rivas Zavaleta N; Álvarez Rodríguez B; Intxausti Irazábal JJ; Jiménez de Aberasturi JRD; Ruibal Escribano A; Maíz Alonso O; Calvo Alén J
    Reumatol Clin (Engl Ed); 2019; 15(6):e96-e98. PubMed ID: 29398465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tocilizumab in uveitis refractory to other biologic drugs: a study of 3 cases and a literature review.
    Calvo-Río V; de la Hera D; Beltrán-Catalán E; Blanco R; Hernandez M; Martínez-Costa L; Loricera J; Cañal J; Ventosa J; Ortiz-Sanjuán F; Pina T; González-Vela MC; Rodríguez-Cundín P; González-Gay MA
    Clin Exp Rheumatol; 2014; 32(4 Suppl 84):S54-7. PubMed ID: 25005576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice.
    Calderón-Goercke M; Loricera J; Aldasoro V; Castañeda S; Villa I; Humbría A; Moriano C; Romero-Yuste S; Narváez J; Gómez-Arango C; Pérez-Pampín E; Melero R; Becerra-Fernández E; Revenga M; Álvarez-Rivas N; Galisteo C; Sivera F; Olivé-Marqués A; Álvarez Del Buergo M; Marena-Rojas L; Fernández-López C; Navarro F; Raya E; Galindez-Agirregoikoa E; Arca B; Solans-Laqué R; Conesa A; Hidalgo C; Vázquez C; Román-Ivorra JA; Lluch P; Manrique-Arija S; Vela P; De Miguel E; Torres-Martín C; Nieto JC; Ordas-Calvo C; Salgado-Pérez E; Luna-Gomez C; Toyos-Sáenz de Miera FJ; Fernández-Llanio N; García A; Larena C; Palmou-Fontana N; Calvo-Río V; Prieto-Peña D; González-Vela C; Corrales A; Varela-García M; Aurrecoechea E; Dos Santos R; García-Manzanares Á; Ortego N; Fernández S; Ortiz-Sanjuán F; Corteguera M; Hernández JL; González-Gay MÁ; Blanco R
    Semin Arthritis Rheum; 2019 Aug; 49(1):126-135. PubMed ID: 30655091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful tocilizumab treatment in a child with refractory Takayasu arteritis.
    Bravo Mancheño B; Perin F; Guez Vázquez Del Rey Mdel M; García Sánchez A; Alcázar Romero PP
    Pediatrics; 2012 Dec; 130(6):e1720-4. PubMed ID: 23147976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.